Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company developing cell therapies for patients suffering from autoimmune diseases.
Kyverna Therapeutics is seeking a Director of SEC Reporting and Technical Accounting to lead the preparation and filing of SEC reports and ensure compliance with U.S. GAAP and SOX requirements. The role requires a strong technical accounting background, experience with SEC reporting, and knowledge of U.S. GAAP and SOX compliance.
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company developing cell therapies for patients suffering from autoimmune diseases.